FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Switzerland

Biotech startups in Switzerland

Updated 16 Nov 2026

Reset
Biotech startups in Switzerland
One-time CSV
  • 207 funded companies, 129 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~switzerland.csv207 rows × 18 columns
CompanyCityLast roundAmountDate
Adaptyv BiosystemsLausanneSeries A$40.0M2026-08-25
Vaderis TherapeuticsBaselSeries B$152.0M2026-08-11
Windward BioBaselSeries B$165.0M2026-05-04
Alithea GenomicsLausanneSeed$3.8M2026-03-04
GlycoEraWädenswilSeries B$130.0M2025-05-27
CutissZürichSeries C$38.8M2025-09-10
Memo TherapeuticsSchlierenSeries C$22.0M2024-05-07
NovaGo TherapeuticsSchlierenSeries B$29.7M2026-08-31

8 rows of the CSV in 5 of its 18 columns.

207
Startups
$4.2B
Total raised
24
Funded in the last 12 months
$659.3M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 207
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
Adaptyv Biosystems Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. Artificial intelligence Lausanne Series A $40.0M 2026-08-25 $50.9M Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 11 to 50 2020
Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
Alithea Genomics Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. Biotech Lausanne Seed $3.8M 2026-03-04 $9.9M Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 11 to 50 2020
Leman Biotech Leman Biotech develops cancer immunotherapies as a biotech company. Biotech Lausanne Series A $28.8M 2026-01-26 $46.8M Tiantu Capital, Fuho Capital 11 to 50 2021
FluoSphera FluoSphera develops drugs. Biotech Geneva Seed $1.4M 2026-01-12 $3.9M SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 1 to 10 2021
FoRx Therapeutics FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. Biotech Basel Series A $50.0M 2025-12-18 $109.4M EQT Life Sciences, Novartis Venture Fund, Omega Funds +2 11 to 50 2019
Genknowme Genknowme is a precision health company advancing epigenetics to support personalized and preventive care. Biotech Lausanne Pre-seed $630K 2025-12-18 $947K Venture Kick, Foundation for Innovation and Technology (FIT) 1 to 10 2019
Hemostod HemostOD manufactures platelets on demand from engineered stem cells. Biotech Lausanne Seed $5.4M 2025-10-01 $7.8M Foundation for Innovation and Technology (FIT) 11 to 50 2020
Cutiss Cutiss is a life science company that produces regenerative medicine and engineers skin tissue. Biotech Zürich Series C $38.8M 2025-09-10 $94.6M Innosuisse 11 to 50 2017
Comphya Comphya develops an active implantable medical device to restore erectile function in patients who do not respond to oral drugs. Biotech Lausanne Series A $4.0M 2025-07-08 $14.2M Venture Kick, Verve Ventures, Nest Collective Foundation 1 to 10 2017
Adiposs Adiposs SA is a clinical-stage life science company developing a first-in-class imaging product for cancer patients. Biotech Geneva Series A $5.0M 2025-06-30 $7.4M MassChallenge, Venture Kick, FONGIT Innovation Fund +2 1 to 10 2020
GlycoEra GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. Biotech Wädenswil Series B $130.0M 2025-05-27 $179.3M Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 11 to 50 2020
CellX Biosolutions CellX Biosolutions provides sustainable treatment of chemical waste. Biotech Zürich Pre-seed $1.9M 2025-02-25 $2.1M Venture Kick, MassChallenge Switzerland 1 to 10 2024
Rhygaze Rhygaze develops a gene therapy that targets cone cells to restore vision in blinding diseases. Biotech Basel Series A $86.0M 2025-01-10 $97.3M Google Ventures, F-Prime, ARCH Venture Partners +2 11 to 50 2024
Noema Pharma Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. Biotech Basel Series B $147.2M 2024-12-11 $316.5M Polaris Partners, Sofinnova Partners, Invus +2 11 to 50 2019
Alentis Therapeutics Alentis Therapeutics develops novel therapeutics for advanced liver disease and cancer. Biotech Allschwil Series D $181.4M 2024-11-12 Bpifrance, HTGF (High-Tech Gruenderfonds), RA Capital Management +2 51 to 100 2019
Translation-X Translation-X is a spin-off project developing novel therapeutics for autism spectrum disorders. Biotech Basel Pre-seed $177K 2024-09-30 Venture Kick 1 to 10 2022
ImmunOs Therapeutics ImmunOs Therapeutics is a clinical-stage biotechnology company. Biotech Schlieren Series C $11.0M 2024-09-17 Lightspeed Venture Partners, Innosuisse, Mission BioCapital +1 11 to 50 2014
Abrinca Genomics Abrinca Genomics is a biotechnology company. Biotech Bern Seed $178K 2024-09-16 Venture Kick 1 to 10 2023
CorFlow Therapeutics CorFlow Therapeutics develops proprietary technologies to diagnose and treat microvascular obstructions. Biotech Baar Series B $48.5M 2024-09-10 $66.1M Innosuisse, Unorthodox Ventures, Panakes Partners +2 11 to 50 2016
Regenosca Regenosca develops biomaterials that serve as alternatives to autologous tissue substitutes for soft tissue repair. Biotech Lausanne Pre-seed $1.1M 2024-07-22 $1.4M MassChallenge, Venture Kick, Foundation for Innovation and Technology (FIT) +1 1 to 10 2019
Asceneuron Asceneuron develops therapeutics for orphan tauopathies and Alzheimer's disease. Biotech Lausanne Series C $100.0M 2024-07-16 OrbiMed, Novo Holdings, EQT Life Sciences +1 1 to 10 2012
iOnctura iOnctura is a clinical-stage biotechnology company developing treatments for cancer. Biotech Geneva Series B $85.7M 2024-06-20 European Innovation Council, M Ventures, VI Partners +2 11 to 50 2017
NXI Therapeutics NXI Therapeutics develops immunosuppressive drugs for autoimmune diseases and organ transplantation. Biotech Basel Pre-seed $4.0M 2024-06-18 $4.0M Venture Kick, Kickfund, Gebert Rüf Stiftung +1 1 to 10 2021
Memo Therapeutics Memo Therapeutics conducts biotechnology research in antibody discovery and immune repertoire analysis. Biotech Schlieren Series C $22.0M 2024-05-07 $108.8M Verve Ventures, Kurma Partners, Pureos Bioventures +1 11 to 50 2012
Neurosterix Neurosterix is a biopharmaceutical firm creating allosteric modulators for neurological illnesses. Biotech Geneva Series A $65.0M 2024-04-03 $65.0M Perceptive Advisors, Xontogeny, Acorn Bioventures 11 to 50 2024
Hemotune Hemotune develops a therapeutic blood purification platform for treating health conditions. Biotech Schlieren Series B $15.6M 2024-03-25 Venture Kick, Innosuisse, Gebert Rüf Stiftung 11 to 50 2016
Myria Biosciences Myria Biosciences discovers natural product drugs using genetically engineered cells that produce them. Biotech Basel Pre-seed $1.9M 2024-01-05 $1.9M Creator Fund 1 to 10 2022

Table 1. Biotech startups in Switzerland: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 207.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
2 Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
3 FoRx Therapeutics FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. Biotech Basel Series A $50.0M 2025-12-18 $109.4M EQT Life Sciences, Novartis Venture Fund, Omega Funds +2 11 to 50 2019
4 Adaptyv Biosystems Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. Artificial intelligence Lausanne Series A $40.0M 2026-08-25 $50.9M Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 11 to 50 2020
5 NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
6 Leman Biotech Leman Biotech develops cancer immunotherapies as a biotech company. Biotech Lausanne Series A $28.8M 2026-01-26 $46.8M Tiantu Capital, Fuho Capital 11 to 50 2021
7 Alithea Genomics Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. Biotech Lausanne Seed $3.8M 2026-03-04 $9.9M Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 11 to 50 2020
8 FluoSphera FluoSphera develops drugs. Biotech Geneva Seed $1.4M 2026-01-12 $3.9M SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 1 to 10 2021
9 Genknowme Genknowme is a precision health company advancing epigenetics to support personalized and preventive care. Biotech Lausanne Pre-seed $630K 2025-12-18 $947K Venture Kick, Foundation for Innovation and Technology (FIT) 1 to 10 2019

Table 2. Biotech startups in Switzerland: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Venture Kick Startup incubator Schlieren, Switzerland 45 22% 2 Adaptyv Biosystems, Genknowme
2 Foundation for Innovation and Technology (FIT) Entrepreneurship program Lausanne, Switzerland 10 5% 3 Adaptyv Biosystems, Alithea Genomics, Genknowme
3 Innosuisse Government investment office Berne, Switzerland 9 4%
4 Novartis Venture Fund Corporate venture arm Basel, Switzerland 9 4% 1 FoRx Therapeutics
5 Novo Holdings Corporate venture arm Hellerup, Denmark 7 3% 1 Windward Bio
6 BioMedPartners Venture capital firm Basel, Switzerland 7 3%
7 MassChallenge Startup accelerator Boston, United States 7 3%
8 VI Partners Venture capital firm Altendorf, Switzerland 6 3%
9 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 6 3% 1 FoRx Therapeutics
10 Versant Ventures Venture capital firm Menlo Park, United States 6 3%
11 Verve Ventures Venture capital firm Zug, Switzerland 5 2%
12 Omega Funds Secondary purchaser Boston, United States 5 2% 1 FoRx Therapeutics
13 OrbiMed Private equity firm New York, United States 4 2% 1 Windward Bio
14 Sofinnova Partners Venture capital firm Paris, France 4 2%
15 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 4 2%

Table 3. Biotech startups in Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 171 83% $3.9B
Software 24 12% $79.4M
Artificial intelligence 12 6% $66.7M
Hardware 8 4% $1.3M
Fintech 3 1%
Education 2 1% $3.6M
Commerce 2 1% $4.7M
Cybersecurity 1 0% $4.7M

Table 4. Biotech startups in Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 27 13% $140K
Seed 67 32% $1.8M
Series A 56 27% $9.4M
Series B 31 15% $26.0M
Series C 20 10% $25.9M
Series D+ 6 3% $134.7M

Table 5. Biotech startups in Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Basel 39 19%
Lausanne 29 14%
Zürich 25 12%
Geneva 21 10%
Schlieren 20 10%
Epalinges 10 5%
Zug 6 3%
Wädenswil 5 2%
Allschwil 4 2%
Ecublens 4 2%
Bern 4 2%
Neuchâtel 3 1%

Table 6. Biotech startups in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 4% $183K
October 2026 2 8% $139.5M
September 2026 2 8% $5.4M
August 2026 3 12% $221.7M
July 2026 1 4% $2.8M
June 2026 2 8% $124K
May 2026 1 4% $165.0M
April 2026 3 12% $21.0M
March 2026 1 4% $3.8M
February 2026 1 4% $873K
January 2026 4 17% $42.7M
December 2025 3 12% $56.3M

Table 7. Biotech startups in Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 21 10% $603.1M
2025 25 12% $564.6M
2024 25 12% $848.4M
2023 15 7% $167.1M
2022 15 7% $198.8M
2021 17 8% $110.1M

Table 8. Biotech startups in Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 21 10%
2020 to 2022 34 17%
2015 to 2019 72 35%
2010 to 2014 38 18%
Before 2010 41 20%

Table 9. Biotech startups in Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 107 52%
11 to 50 79 39%
51 to 100 15 7%
101 to 250 2 1%
251 to 500 1 0%
1,001 to 5,000 1 0%

Table 10. Biotech startups in Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Switzerland are on the list?
207, in the file dated 16 November 2026. 24 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 207 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Switzerland: 207 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Switzerland by funding stage

Other sectors in Switzerland

Biotech startups elsewhere

Cite: FundingWatcher, 207 funded biotech companies in Switzerland, 16 November 2026. https://fundingwatcher.com/startups/biotech/switzerland/